All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

FormBlends Tools

Personalized GLP-1 Journey Planner

Build one printable planning summary that connects eligibility, titration, expected timeline, nutrition, side-effect readiness, medication review flags, provider comparison, and pharmacy safety checks.

GLP-1 journey planner dashboard connecting eligibility, cost, dosing schedule, nutrition, timeline, and safety checks
The journey planner combines eligibility, cost, dosing schedule, nutrition, timeline, and safety checks in one printable plan.

Profile

Health and treatment inputs

Weight-related conditions

Current medications

Diabetes

Thyroid

Hormones

Blood thinners

Blood pressure

Cholesterol

Mental health

Stomach/GI

Pain relief

Anti-inflammatory

Fluid balance

Anxiety

Supplements

Plan

Personalized GLP-1 snapshot

Eligibility

Needs inputs
Add height and weight. Height and weight are needed to screen basic GLP-1 eligibility.

Timeline

Needs goal
Add current and goal weight to model a timeline.

Nutrition

Needs age
Add age, height, weight, and activity.

Medication flags

None
Add current medications to screen common GLP-1 planning flags.

Dose schedule

Weeks 1-4

0.25 mg

Once weekly

May 31, 2026 - Jun 27, 2026

Starter phase focused on tolerability.

Weeks 5-8

0.5 mg

Once weekly

Jun 28, 2026 - Jul 25, 2026

First escalation; appetite effects often become more noticeable.

Weeks 9-12

1.0 mg

Once weekly

Jul 26, 2026 - Aug 22, 2026

Therapeutic range for many patients.

Weeks 13-16

1.7 mg

Once weekly

Aug 23, 2026 - Sep 19, 2026

Higher efficacy phase; monitor GI tolerance.

Week 17+

2.4 mg

Once weekly

Starts Sep 20, 2026

Common labeled maintenance target for weight management.

Side-effect readiness

Nausea20%

Smaller meals, slower eating, lower-fat foods, and delayed escalation if needed.

Diarrhea15%

Hydration and provider review if persistent or severe.

Constipation12%

Fluids, fiber as tolerated, movement, and clinician-approved stool softeners.

Headache10%

Hydration, regular meals, and blood-pressure review if recurring.

Vomiting8%

Call a clinician for repeated vomiting or dehydration symptoms.

Abdominal pain8%

Track severity and seek care for intense or persistent pain.

Open side-effect protocol engine

Nutrition targets

Complete age, sex, height, weight, and activity to calculate targets.

Cost and provider path

Modeled monthly

$199

Modeled total

$1,194

Add a monthly budget to compare affordability.

Questions for your clinician

  1. Based on my BMI, health history, and current medications, am I a candidate for Semaglutide?
  2. Which labs should I complete before starting and when should we recheck them?
  3. What dose-escalation pace would you choose if I have nausea, reflux, constipation, or fatigue?
  4. How should I adjust protein, fluids, and resistance training to reduce muscle loss risk?
  5. What documentation would support prior authorization or an appeal for my plan?

Next actions

  • Confirm eligibility, contraindications, and medication history with a licensed clinician.
  • Document baseline weight, waist, blood pressure, current medications, and recent labs before starting.
  • Create a weekly injection reminder and rotate sites instead of repeating the same area.

Red flags

Seek urgent medical guidance for severe or persistent abdominal pain, repeated vomiting, dehydration, signs of allergic reaction, fainting, very low blood sugar symptoms, pregnancy, or any symptom that feels sudden or unsafe.

Methodology

This planner uses a shared local profile to combine BMI screening, weight-loss timeline modeling, standard GLP-1 titration patterns, nutrition estimates from Mifflin-St Jeor, clinical-trial average side-effect rates, and common medication review flags. Compounded medications are not FDA-approved, and public pharmacy registration data should be verified against official sources.

Timeline and cost outputs are planning estimates. They do not predict individual results, insurance approval, medication availability, prescribing eligibility, or safety.